CSIMarket Company Name, Ticker, Competitors, else..
 
Strata Skin Sciences Inc  (NASDAQ: SSKN)
 
Price: $0.0050 $0.00 0.000%
Day's High: $0.004999999888241291 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: 4900 %
Volume (M): 8,333 52 Wk High: $ 3.04
Volume (M$): $ 0 52 Wk Avg: $0.71
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 5
 Employees 114
 Revenues (TTM) (Millions $) 29
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 2

Business Description


Strata Skin Sciences Inc is a medical technology company primarily focused on the dermatology market. The company develops, manufactures, and markets innovative devices for treating various skin conditions and diseases. Their flagship product is the XTRAC laser system, which is used to treat psoriasis, vitiligo, and other skin disorders.

The XTRAC laser system uses a targeted phototherapy technology that delivers concentrated ultraviolet light to affected areas of the skin, providing a safe and effective treatment option. The company also provides training, support, and service to healthcare professionals who use their devices.

In addition to the XTRAC laser system, Strata Skin Sciences Inc offers other dermatological devices, such as the Nordlys device for vascular and pigmented lesions, and the STRATAPEN microneedling device for skin rejuvenation and scar treatment.

The company has a global presence and serves customers in over 70 countries. They are committed to continuous innovation and investing in research and development to expand their product portfolio and improve patient outcomes.


   Company Address: 5 Walnut Grove Drive Horsham 19044 PA
   Company Phone Number: 619-3200   Stock Exchange / Ticker: NASDAQ SSKN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX   -6.1%    
BSX   -7.83%    
CNMD   -6.26%    
IART   -5.29%    
INMD   -0.47%    
MDT   -2.35%    
• View Complete Report
   



Clinical Study

Novel Excimer Laser Therapy and TheraClearX System Display Promising Outcomes in Dermatological Treatments

Published Tue, Oct 14 2025 1:45 PM UTC

: This article presents a critical analysis of recent advancements in dermatological treatments focusing on two pivotal studies: the application of 308-nm Excimer laser in treating the uncommon subtype of Mycosis Fungoides, poikilodermatous mycosis fungoides (pMF), and the efficacy and safety of STRATA Skin Sciences TheraClearX Acne Therapy System. The emerging clinical ev...
Clinical Study

Combination Therapy for Vitiligo Enhanced Efficacy with STRATA Skin Sciences Excimer Laser and JAK Inhibitors

Published Mon, Sep 22 2025 12:23 PM UTC

Vitiligo, an autoimmune skin disorder characterized by the loss of pigment, poses significant therapeutic challenges. Recent advancements have highlighted the potential for combination therapies to enhance treatment efficacy and safety for patients. A pivotal study, published in the International Journal of Dermatology , provides new evidence supporting the combined use of ...
Product Service News

STRATA Skin Sciences Achieves Legal Victory Amidst Market Challenges

Published Mon, Nov 11 2024 1:15 PM UTC

In a notable development that may signal a turning tide for STRATA Skin Sciences, Inc. (NASDAQ: SSKN), the medical technology firm has recently secured a favorable ruling from the United States District Court for the Eastern District of Pennsylvania. This court order comes as a positive advance in the company’s ongoing complaint against a trio of defendants: LaserOptek Ame...
Stocks on the Move

Strata Skin Sciences’ Stock Stumble A Promising Therapy Clouded by Financial Concerns, refusal null

Published Tue, Aug 6 2024 9:11 PM UTC

Behind the Decline: Why Strata Skin Sciences Inc Shares Are Lagging the MarketIn recent days, the shares of Strata Skin Sciences Inc (NASDAQ: SSKN) have found themselves on a downward trajectory, trailing the performance of the broader market despite noteworthy advancements in its technology and promising developments in acne treatment. This paradox raises questions about t...
Management Announcement

Faith in Future Prospects: STRATA Skin Sciences Raises $2.1 Million in Direct Offering with Insider and Shareholder Participation Amidst Challenging Financial Climate

Published Tue, Jul 23 2024 12:01 PM UTC


: July 23, 2024
Horsham, PA - STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leading medical technology company specializing in innovative dermatologic treatments, has recently completed a registered direct offering to raise $2.1 million. The offering, priced at-the-market under Nasdaq rules, saw the issuance and sale of 665,136 shares of common stock at an average pu...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.00
Price to Sales (Expected) -
Price to Book 0.01
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.28
Working Capital Ratio 0.56
Leverage Ratio (MRQ) 15.08
Total Debt to Equity 10.64
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.48 $
Revenues (TTM) 6.33 $
Cash Flow (TTM) -
Cash 1.7 $
Book Value 0.63 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 258,149
Net Income per Employee (TTM) -56,886
Receivable Turnover Ratio (TTM) 7.07
Inventory Turnover Ratio (TTM) 3.97
Asset Turnover Ratio (TTM) 0.77

Profitability Ratios Current
Gross Margin (MRQ) 60.42 %
Operating Margin (MRQ) 0 %
Net Margin (MRQ) 0.62 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Strata Skin Sciences Inc's Segments
Dermatology Recurring Procedures    71.11 % of total Revenue
Dermatology Procedures Equipment    31.37 % of total Revenue
Domestic    66.15 % of total Revenue
China    12.55 % of total Revenue
Middle East    10.7 % of total Revenue
Other Foreign    13.09 % of total Revenue
Domestic Dermatology Recurring Procedures    63.91 % of total Revenue
Domestic Dermatology Procedures Equipment    2.24 % of total Revenue
China Dermatology Procedures Equipment    12.55 % of total Revenue
Middle East Dermatology Procedures Equipment    10.7 % of total Revenue
Other Foreign Dermatology Recurring Procedures    7.21 % of total Revenue
Other Foreign Dermatology Procedures Equipment    5.88 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.